"The first therapeutic vaccine against lung cancer, Cimavax, received the sanitary registration in Belarus," the minister said on social media on Sunday.
The Cuban pharmaceuticals industry continues to deliver great results despite restrictions stemming from the United States' embargo, he added.
The Cimavax vaccine, produced by Cuba's Center for Molecular Immunology, is the world's first officially patented and registered vaccine against lung cancer. The treatment allows the immune system to form neutralizing antibodies against epidermal growth factor (EGF).